EPCAM and hepatocellular carcinoma: To further prove this finding, we used two well-recognized markers, EpCAM and CD133, to characterize the subpopulation of HCC stem cells, and found that CANA treatment significantly decreased the proportions of CD133- and EpCAM-positive HuH7 cells (Fig. 1e).